Latest Stock Research & Market Analysis
Search All Research, Articles & Stock Profiles
ASX Stock Research
[BUY] Nick Scali (ASX: NCK): Margins, Growth and a Franked Yield
Institutional sell-side rates Nick Scali a Buy with a 12-month price target of around A$20. The stock closed at approximately A$14.47 on 9 May 2026, implying roughly 38 per cent upside before dividends. The thesis is built on three pillars: ANZ gross margins that sit...
[BUY] ResMed (ASX: RMD) – A New Product Cycle and a Cheap Multiple
ResMed reported its 3Q26 result this week. We are reiterating our Buy view on the stock with a price target of A$46.20, against a closing price of A$28.73 on 1 May 2026 and roughly 60.8 per cent upside to that target. The thesis is straightforward. Top-line growth...
[SELL] Macquarie Group (ASX: MQG) Why a 21% Rally Into Earnings Looks Stretched
Macquarie has rallied more than 21% in the past month, pushing the multiple to 24x forward earnings against a 10-year average of 16x. We walk through why the valuation looks stretched, the bull-case rebuttals (Aligned Data Centers, Qube), and why FY26 result on 8 May is the decision point.
[BUY] PWR Holdings (ASX: PWH) – De-risked and Returning to Growth
PWR Holdings (ASX PWH) - De-risked and Returning to Growth PWR Holdings (ASX: PWH) designs and manufactures advanced cooling solutions for the world's most demanding...
[BUY] BHP (ASX: BHP) Escondida Expansion Cements the Copper Growth Story
BHP has submitted a larger expansion proposal for the Escondida New Concentrator (ENC) project in Chile, upsizing the plant by roughly 20% and bringing forward an estimated...
Global Marco and Market Research
Australia’s Biggest CGT Change in 25 Years. What It Means for Investors.
The FY2027 Commonwealth Budget delivered the biggest change to capital gains tax since 1999. Institutional sell-side economics research assessed the Budget as broadly deficit-neutral at the headline level but incrementally expansionary for GDP growth once off-balance...
The Australian Consumer Was Already Last in the G10 on Spending. The RBA Hiked Anyway.
The G10 consumer dashboard puts Australian household spending growth dead last in the developed-market cohort. Tuesday’s RBA hike to 4.35 percent continues the squeeze. What that means for a domestic portfolio.
The Q1 CPI Was Mixed. The RBA Still Has to Hike on Tuesday.
The Reserve Bank Board meets on Monday and Tuesday next week with a rate decision at 2:30pm AEST on Tuesday. This is the most anticipated single-meeting call we have had in nine months. The case rests on a Q1 CPI print released on Wednesday that did two things at...
Global Stock Research
[BUY] Upwork (NASDAQ: UPWK) – Restructuring Sharpens the Margin Story
Upwork delivered a Q1'26 result that landed on the right side of a bifurcated narrative. Revenues came in around the midpoint of guidance at $195mn, while Adj. EBITDA of $57mn came in nearly 24% above consensus expectations, with the margin beat tracing back to a cost...
[BUY] Eli Lilly (LLY): Foundayo Reframes the Oral GLP-1 Story
LLY Buy with ~37% upside to ~US$1,283. 1Q26 EPS US$8.55 beat US$6.77, 2026 guide raised to US$82-85bn. Foundayo oral GLP-1 hits 8k prescribers in 3 weeks, 80% new incretin patients.
[HOLD] Tesla (NASDAQ: TSLA) A Strong Q1 But No Free Cash Flow Until 2028
Tesla (NASDAQ: TSLA) A Strong Q1 But No Free Cash Flow Until 2028 Tesla just delivered a first quarter result that was stronger than the market expected, with revenue beating the Street, automotive gross margins running well ahead of forecast, and energy storage...
[BUY] Corvus Pharmaceuticals (CRVS) – Novel and Differentiated Contender in Auto-Immune and Hematology
Corvus Pharmaceuticals has developed soquelitinib, a first-in-class oral ITK inhibitor targeting moderate-to-severe atopic dermatitis and relapsed/refractory peripheral T cell lymphoma. We initiate at Buy with a 12-month price target of $40.
[BUY] Broadcom (AVGO) – Three Hyperscaler Partnerships Lock In the Custom Silicon Growth Story
Broadcom has cemented its position as the dominant custom silicon and AI networking partner across the three largest US hyperscalers in the space of a single week. A long-term...
Region & Industry Outlook
Why China Is Pricing a Stability Premium
China has spent three years priced for an accident. In 2026 the macro picture has flipped, with growth holding above 4.5%, inflation reflating off the floor, USD/CNY rolling lower, and the equity wrappers leading the rerating off the 2024 lows.
Why Gold Miners Still Have Room to Run
Gold has had a turbulent few months. Spot gold ran from around US$3,400/toz at the end of 2025 to a peak above US$5,300/toz in early 2026 on a wave of speculative call-option demand and continued central bank diversification. The Iran shock in late March then...
Semis Are Still Riding the AI Capex Wave
The semiconductor cycle is in a constructive setup, with the AI capital expenditure build-out continuing to pull through capacity commitments, design wins, and sub-segment by sub-segment recoveries. March monthly shipment data from the Semiconductor Industry...
ASX Announcement
Westpac Banking Corporation (ASX: WBC) – Suspends Hybrid Notes from Official Quotation
Westpac Banking Corporation has redeemed EUR 1 billion of 0.766% Notes ahead of their originally scheduled maturity date, triggering the suspension and removal of the securities from official quotation. The notes, trading under ASX code WBCHDF and originally scheduled...
PointsBet Holdings (ASX: PBH) – PointsBet Files FY26 Investor Presentation
I can't write this commentary as provided. The text you've shared is almost entirely the legal disclaimer and "Important Notice" section of the presentation. There's no actual announcement content, financial results, metrics, strategic initiatives, or news to analyze....
PointsBet Holdings (ASX: PBH) – PointsBet Files Preliminary Final Report 2026
PointsBet Holdings Limited reported deteriorating financial results for the nine-month period ended 31 March 2026, with net losses expanding to AUD 26.6 million despite completing a shorter reporting period than the prior corresponding twelve-month year. The company...
Vicinity Centres (ASX: VCX) – Vicinity Acquires Eastern Creek Quarter Retail Asset
Vicinity Centres has exchanged contracts to acquire Eastern Creek Quarter, a hybrid retail asset in Western Sydney, for $400 million, with settlement expected on 30 June 2026....
Meridian Energy (ASX: MEZ) – Meridian April 2026 Monthly Operating Report
Meridian Energy's April 2026 monthly operating report reveals an exceptionally well-positioned hydro system as the country enters the cooler months. National electricity storage...
Top Stock Reports
5 Best Shares to Buy Right Now in Australia
Finding the best shares to buy on the ASX requires more than just scanning a screener or chasing whatever is up this week. We focus on companies with strong competitive positioning, visible earnings growth, and a catalyst to drive the share price higher over the next...
5 Best US Shares to Buy Right Now
US equities offer Australian investors access to some of the most innovative and fastest-growing companies in the world. The sheer depth of the American market means there are opportunities across sectors that simply do not exist on the ASX, from cutting-edge biotech...
5 Best Dividend Stocks to Buy [ASX Blue Chip Stocks]
Dividend investing on the ASX remains one of the most reliable ways to build long-term wealth. Blue chip dividend stocks offer a combination of regular income and capital growth that is difficult to replicate through other strategies, particularly in an environment...
Subscribe
Want more Free Research?
Subscribe today for free and get an alert when we have new research and webinars.
MF & Co. Asset Management
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Contact
Get In Touch
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000